
Patients with cognitive impairment or dementia require an accurate and early diagnosis, an assessment of the cognitive areas of impairment and the severity of the damage, the application of appropriate therapeutic measures and the monitoring of the often progressive course and possible complications. Several clinical and basic disciplines are involved in these tasks.
The Clinical Platform was created with a translational vocation to investigate the clinical-evolutionary knowledge of neurodegenerative pathologies, as a mediation of the basic and social sciences involved in their study, and to explore new ways of their treatment. At the Clinical Platform, the priority is to advance knowledge of neurodegenerative diseases that cause dementia, especially Alzheimer's disease, in order to ultimately obtain better treatment for those who suffer directly or indirectly from them.
A team of specialists in Neurology, Neuropsychology and Nursing make up the Platform and collaborate with geriatricians, occupational therapists, physiotherapists and social workers in the care area of the Queen Sofia Foundation Alzheimer Centre. The following tasks are carried out there:
PhD in Medicine, specialist in Neurology - IP and responsible for the group
PhD in Medicine, specialist in Neurology
PhD in Medicine, specialist in Neurology - Coordinator Madrid-DFT
Graduate in Psychology, Postgraduate in Neuropsychology
Graduate in Psychology, Postgraduate in Neuropsychology
PhD in Health Sciences. Lic. in Psychology - Coordinator SCAP-AD
Doctor, specialist in Neurology. PhD student.
Graduate in nursing with a postgraduate degree in teaching.
Secretary of the Clinical Assessment Platform
Lines of research
The interests of the CIEN Clinical Evaluation Platform are focused on the following priority lines of research:
Plasma Neurodegenerative Biomarkers in Cognitively Preserved Nonagenarians
This study investigates neurodegenerative biomarkers in plasma of cognitively preserved nonagenarians, providing information on healthy ageing.Trajectory of Cognitive Decline Before and After Stroke in 14 Population Cohorts
This article analyses the trajectory of cognitive decline before and after stroke in 14 population cohorts, providing a comprehensive view of stroke-associated cognitive changes.Additive Impact of Cardiometabolic Multimorbidity and Depression on Cognitive Decline: Findings from Multi-Regional Cohorts and Generalization from Community to Clinic
Research addresses how cardiometabolic multimorbidity and depression jointly affect cognitive decline, based on data from multiple regional cohorts.Dimensions of Cognitive Reserve and Their Predictive Power of Cognitive Performance and Decline in the Elderly
This study explores how different dimensions of cognitive reserve can predict cognitive performance and decline in older people.Education and Literacy as Risk Factors of Dementia after Stroke and Transient Ischemic Attack: NEDICES Study
This article examines how education and literacy act as risk factors for dementia after stroke and transient ischemic attack, according to the NEDICES study.The Health Status: The Ignored Risk Factor in Dementia Incidence. NEDICES Cohort
This study highlights health status as an ignored risk factor in dementia incidence, based on the NEDICES cohort.Predementia Constructs: Mild Cognitive Impairment or Mild Neurocognitive Disorder? A Narrative Review
This narrative review analyses predementia constructs, comparing mild cognitive impairment with mild neurocognitive disorder.Impact of Individual and Neighborhood Dimensions of Socioeconomic Status on the Prevalence of Mild Cognitive Impairment Over Seven-Year Follow-Up
This study investigates how individual and neighbourhood dimensions of socioeconomic status impact on the prevalence of mild cognitive impairment over a seven-year follow-up.Combined Alzheimer's Disease and Cerebrovascular Staging Explains Advanced Dementia Cognition
Research suggests that combined staging of Alzheimer's disease and cerebrovascular status may explain cognition in advanced dementia.Effects of Commonly Prescribed Drugs on Cognition and Mild Cognitive Impairment in Healthy Elderly People
This study evaluates how commonly prescribed drugs affect cognition and mild cognitive impairment in healthy elderly people.